Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sophonix is a China-based in vitro diagnostics company focused on the development, production, sales, and service of diagnostic instruments and reagents. The company markets automated chemiluminescence immunoassay analyzers, pathology diagnostic systems including automated immunohistochemical staining instruments, and molecular diagnostic systems based on isothermal nucleic acid amplification. Its product portfolio is positioned for point-of-care and hospital laboratory use across infectious disease, oncology, neurology, cardiovascular, endocrine, and maternal-child health testing. Publicly available sources describe Sophonix as an active private company founded in 2017 and headquartered in Beijing, with dual R&D centers in Beijing and California. The business appears to be a commercial-stage diagnostics platform company rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sophonix.